A

ADmit Therapeutics

9 employees

ADmit Therapeutics is a biotechnology company intended to develop a test for early diagnosis of Alzheimer.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Diagnostics
Health Care
Epigenetics
Pharmaceutical
Alzheimer's disease
Next Generation Sequencing
Dementia

Date founded

2017

Funding rounds raised

Total raised

$225K

from 1 investors over 1 rounds

A

ADmit Therapeutics raised $225K on March 27, 2019

Investors: Ship2B

FAQ